Gagan Dhawan

1.4k total citations · 1 hit paper
27 papers, 1.0k citations indexed

About

Gagan Dhawan is a scholar working on Molecular Biology, Organic Chemistry and Pharmaceutical Science. According to data from OpenAlex, Gagan Dhawan has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Organic Chemistry and 8 papers in Pharmaceutical Science. Recurrent topics in Gagan Dhawan's work include Fluorine in Organic Chemistry (8 papers), Chemical Synthesis and Analysis (3 papers) and Click Chemistry and Applications (3 papers). Gagan Dhawan is often cited by papers focused on Fluorine in Organic Chemistry (8 papers), Chemical Synthesis and Analysis (3 papers) and Click Chemistry and Applications (3 papers). Gagan Dhawan collaborates with scholars based in India, United States and China. Gagan Dhawan's co-authors include Wei Zhang, Jianlin Han, Heerak Chugh, Vadim A. Soloshonok, Pradeep Kumar, Indu Singh, Ramesh Chandra, Damini Sood, Vartika Tomar and Seema Gupta and has published in prestigious journals such as Journal of Medicinal Chemistry, Green Chemistry and Chemistry - A European Journal.

In The Last Decade

Gagan Dhawan

26 papers receiving 996 citations

Hit Papers

Fluor... 2025 2026 2025 5 10 15 20
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Fluorine in the Pharmaceutical Industry: FDA‐Approved Fluorine‐Containing Drugs in 2024
    2025 22 citations Daniel Baecker, Gagan Dhawan et al. Chemistry - A European Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gagan Dhawan India 15 372 275 239 202 193 27 1.0k
Mamata Singh India 14 198 0.5× 129 0.5× 326 1.4× 234 1.2× 113 0.6× 46 1.0k
Jiaqi Song China 17 190 0.5× 64 0.2× 254 1.1× 149 0.7× 153 0.8× 65 912
Xiu-Rong Hu China 18 160 0.4× 112 0.4× 177 0.7× 252 1.2× 153 0.8× 81 859
Fioretta Asaro Italy 23 452 1.2× 99 0.4× 375 1.6× 138 0.7× 201 1.0× 76 1.4k
Samir Mandal India 20 319 0.9× 53 0.2× 300 1.3× 179 0.9× 107 0.6× 84 1.1k
Keda Zhang China 19 202 0.5× 78 0.3× 288 1.2× 126 0.6× 125 0.6× 66 876
Xuling Wang China 9 360 1.0× 193 0.7× 454 1.9× 57 0.3× 163 0.8× 13 1.2k
Jitendra Wankar Italy 9 123 0.3× 129 0.5× 148 0.6× 133 0.7× 156 0.8× 12 644
Hanqing Zhao China 18 135 0.4× 236 0.9× 254 1.1× 219 1.1× 318 1.6× 51 998

Countries citing papers authored by Gagan Dhawan

Since Specialization
Citations

This map shows the geographic impact of Gagan Dhawan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gagan Dhawan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gagan Dhawan more than expected).

Fields of papers citing papers by Gagan Dhawan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gagan Dhawan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gagan Dhawan. The network helps show where Gagan Dhawan may publish in the future.

Co-authorship network of co-authors of Gagan Dhawan

This figure shows the co-authorship network connecting the top 25 collaborators of Gagan Dhawan. A scholar is included among the top collaborators of Gagan Dhawan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gagan Dhawan. Gagan Dhawan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Jianlin, Alicja Wzorek, Gagan Dhawan, et al.. (2025). CHIRAL, FLUORINE-CONTAINING PHARMACEUTICALS. 91(2). 55–90. 6 indexed citations
2.
Baecker, Daniel, Gagan Dhawan, Lóránd Kiss, et al.. (2025). Fluorine in the Pharmaceutical Industry: FDA‐Approved Fluorine‐Containing Drugs in 2024. Chemistry - A European Journal. 31(25). e202500662–e202500662. 22 indexed citations breakdown →
3.
Wang, Qian, Gagan Dhawan, Wei Zhang, et al.. (2024). FDA approved fluorine-containing drugs in 2023. Chinese Chemical Letters. 35(11). 109780–109780. 46 indexed citations
4.
Han, Jianlin, Alicja Wzorek, Gagan Dhawan, et al.. (2024). NEW DRUGS ON THE PHARMACEUTICAL MARKET CONTAINING FLUORINE AND RESIDUES OF TAILOR-MADE AMINO ACIDS. 90(9). 31–56. 7 indexed citations
5.
Han, Jianlin, Alicja Wzorek, Gagan Dhawan, et al.. (2024). New drugs appearing on the market in 2023: molecules containing fluorine and fragments of tailor-made amino acids. 19(1). 3–20. 12 indexed citations
6.
Wang, Nana, Haibo Mei, Gagan Dhawan, et al.. (2023). New Approved Drugs Appearing in the Pharmaceutical Market in 2022 Featuring Fragments of Tailor-Made Amino Acids and Fluorine. Molecules. 28(9). 3651–3651. 32 indexed citations
7.
Li, Ziyi, Gagan Dhawan, Wei Zhang, et al.. (2022). Fluorine-containing drugs approved by the FDA in 2021. Chinese Chemical Letters. 34(1). 107578–107578. 122 indexed citations
8.
Singh, Ashish Kumar, et al.. (2022). Exploring the role of framework mutations in enabling breadth of a cross-reactive antibody (CR3022) against the SARS-CoV-2 RBD and its variants of concern. Journal of Biomolecular Structure and Dynamics. 41(6). 2341–2354. 6 indexed citations
9.
Khanna, Madhu, et al.. (2022). Pharmacological Manipulation of UPR: Potential Antiviral Strategy Against Chikungunya Virus. Indian Journal of Microbiology. 62(4). 634–640. 1 indexed citations
10.
Sigua, Logan H., Tingjian Wang, Deyao Li, et al.. (2021). Development of Dimethylisoxazole-Attached Imidazo[1,2-a]pyridines as Potent and Selective CBP/P300 Inhibitors. Journal of Medicinal Chemistry. 64(9). 5787–5801. 22 indexed citations
11.
Dhawan, Gagan, Indu Singh, Uma Dhawan, & Pradeep Kumar. (2021). Synthesis and Characterization of Nanoselenium: A Step-by-Step Guide for Undergraduate Students. Journal of Chemical Education. 98(9). 2982–2989. 20 indexed citations
12.
Yu, Yingjie, Gagan Dhawan, Haibo Mei, et al.. (2021). Fluorine-containing pharmaceuticals approved by the FDA in 2020: Synthesis and biological activity. Chinese Chemical Letters. 32(11). 3342–3354. 141 indexed citations
13.
Khanna, Madhu, et al.. (2021). Targeting unfolded protein response: a new horizon for disease control. Expert Reviews in Molecular Medicine. 23. e1–e1. 30 indexed citations
14.
15.
Singh, Indu, Gagan Dhawan, Seema Gupta, & Pradeep Kumar. (2021). Recent Advances in a Polydopamine-Mediated Antimicrobial Adhesion System. Frontiers in Microbiology. 11. 607099–607099. 117 indexed citations
16.
Chugh, Heerak, et al.. (2020). A comprehensive review on potential therapeutics interventions for COVID-19. European Journal of Pharmacology. 890. 173741–173741. 27 indexed citations
17.
Chugh, Heerak, Pramod Kumar, Neeraj Kumar, et al.. (2020). Ex vivo binding studies of the anti-cancer drug noscapine with human hemoglobin: a spectroscopic and molecular docking study. New Journal of Chemistry. 45(3). 1525–1534. 10 indexed citations
18.
Singh, Indu, Ayushi Priyam, Diksha Jha, et al.. (2019). Polydopamine –aminoglycoside nanoconjugates: Synthesis, characterization, antimicrobial evaluation and cytocompatibility. Materials Science and Engineering C. 107. 110284–110284. 20 indexed citations
19.
20.
Zhang, Xiaofeng, et al.. (2017). One-pot and catalyst-free synthesis of pyrroloquinolinediones and quinolinedicarboxylates. Green Chemistry. 19(16). 3851–3855. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mamata Singh Breakdown of academic impact, for papers by Jiaqi Song Breakdown of academic impact, for papers by Xiu-Rong Hu Breakdown of academic impact, for papers by Fioretta Asaro Breakdown of academic impact, for papers by Samir Mandal Breakdown of academic impact, for papers by Keda Zhang Breakdown of academic impact, for papers by Xuling Wang Breakdown of academic impact, for papers by Jitendra Wankar Breakdown of academic impact, for papers by Hanqing Zhao
Rankless by CCL
2026